Abstract 4119868: Statin and PCSK9 Inhibitor Utilization and Spending in Medicaid between 2018 to 2022: A National Analysis
Circulation
NOVEMBER 11, 2024
Introduction:Low-income working-aged adults in the Medicaid program have a high burden of cardiovascular risk factors and disease, but often face barriers accessing necessary therapies. However, Medicaid spending on statins decreased by 7.1%, from $246.2 million statin prescriptions in 2018 compared to 20.3 million to $226.8
Let's personalize your content